Lupin Limited has informed the Exchange regarding a press release dated January 07, 2022, titled "Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India.".
Lupin Limited has informed the Exchange regarding a press release dated January 07, 2022, titled "Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India.".